Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease.
Prostate cancer is the most common cancer among men and the second-leading cause of cancer deaths, according to UC San Francisco (UCSF).
But if screening programs are introduced on a national scale — particularly those that measure levels of prostate-specific antigen (PSA) in the blood — they could give men earlier access to treatment, experts say.
Check out the video and accompanying story here.
